Conflict of Interest

Identification and management of conflicts of interest preserve the objectivity and credibility of programs and processes at Canada’s Drug Agency (CDA-AMC), and are intended to ensure the highest ethical standards and maintenance of integrity of the work undertaken and/or sponsored by the agency. CDA-AMC has conflict of interest policies and guidelines in place for all employees, external experts, committee or panel members, and individuals contracted by the agency. All experts, patient representatives, and CDA-AMC staff members involved in the Scientific Advice program are bound by the conflict of interest policies and guidelines.
 

Conflict of Interest and Scientific Advice

Current members of the Canadian Drug Expert Committee (CDEC) or the pan-Canadian Oncology Drug Review Expert Review Committee (pERC) will not participate in the Scientific Advice program; however, past members of CDEC or pERC or those with terms ending may participate, if appropriate.

A current member of CDEC or pERC, who has participated in providing Scientific Advice for a drug before an appointment on the committee, will not participate in discussions, deliberations, and recommendations for the same drug and indication if it is later submitted to CDA-AMC through the Reimbursement Review program.

 Experts who have knowledge of the contents of the Record of Scientific Advice for a drug, or who have attended the Scientific Advice meeting for a drug, will not participate in the review for the same drug with the same indication when submitted to CDA-AMC through the Reimbursement Review program. Exceptions may apply.

The same external experts, patient representatives, and Scientific Advice staff may participate in providing Scientific Advice for similar or competing drugs (refer to the Scientific Advice Disclaimer). Note that all external experts, patient representatives, and Scientific Advice staff are required to sign the Nondisclosure Agreement and to comply with the Confidentiality Guidelines for Scientific Advice.

For links to CDA-AMC conflict of interest guidelines and policies, please refer to Conflict of Interest.